To further investigate this potential mechanism, we treated alveolar type 2 cells with TGFβ in the absence or presence of the synthetic TLR3 agonist, polyinosinic:polycytidylic acid (poly I:C), to mimic viral infection. The gene discussed is TLR3; the disease is viral infectious disease.